136 related articles for article (PubMed ID: 26056083)
1. Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma.
Di Martino MT; Guzzi PH; Caracciolo D; Agnelli L; Neri A; Walker BA; Morgan GJ; Cannataro M; Tassone P; Tagliaferri P
Oncotarget; 2015 Aug; 6(22):19132-47. PubMed ID: 26056083
[TBL] [Abstract][Full Text] [Related]
2. Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease.
Bruno T; Catena V; Corleone G; Cortile C; Cappelletto MC; Bellei B; De Nicola F; Amadio B; Gumenyuk S; Marchesi F; Annibali O; Blandino G; Fanciulli M; Di Agostino S
Leukemia; 2024 Apr; 38(4):877-882. PubMed ID: 38368441
[No Abstract] [Full Text] [Related]
3. Using dual-network-analyser for communities detecting in dual networks.
Guzzi PH; Tradigo G; Veltri P
BMC Bioinformatics; 2022 Jan; 22(Suppl 15):614. PubMed ID: 35012460
[TBL] [Abstract][Full Text] [Related]
4. miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy.
Di Martino MT; Riillo C; Scionti F; Grillone K; Polerà N; Caracciolo D; Arbitrio M; Tagliaferri P; Tassone P
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808190
[TBL] [Abstract][Full Text] [Related]
5. Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma.
Allegra A; Ettari R; Innao V; Bitto A
Cells; 2021 Feb; 10(2):. PubMed ID: 33672466
[TBL] [Abstract][Full Text] [Related]
6. Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing.
Kumar Das J; Tradigo G; Veltri P; H Guzzi P; Roy S
Brief Bioinform; 2021 Mar; 22(2):855-872. PubMed ID: 33592108
[TBL] [Abstract][Full Text] [Related]
7. Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats.
Di Martino MT; Arbitrio M; Caracciolo D; Scionti F; Tagliaferri P; Tassone P
Mol Ther Nucleic Acids; 2020 Jun; 20():73-85. PubMed ID: 32146420
[TBL] [Abstract][Full Text] [Related]
8. L-HetNetAligner: A novel algorithm for Local Alignment of Heterogeneous Biological Networks.
Milano M; Milenković T; Cannataro M; Guzzi PH
Sci Rep; 2020 Mar; 10(1):3901. PubMed ID: 32127586
[TBL] [Abstract][Full Text] [Related]
9. Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing.
Agnelli L; Bisognin A; Todoerti K; Manzoni M; Taiana E; Galletti S; Cutrona G; Gaffo E; Bortoluzzi S; Neri A
Blood Cancer J; 2019 Feb; 9(3):21. PubMed ID: 30783080
[TBL] [Abstract][Full Text] [Related]
10. From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology.
Gallo Cantafio ME; Grillone K; Caracciolo D; Scionti F; Arbitrio M; Barbieri V; Pensabene L; Guzzi PH; Di Martino MT
High Throughput; 2018 Oct; 7(4):. PubMed ID: 30373182
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel targets for multiple myeloma through integrative approach with Monte Carlo cross-validation analysis.
Liu C; Gu X; Jiang Z
J Bone Oncol; 2017 Sep; 8():8-12. PubMed ID: 28856086
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.
Soley L; Falank C; Reagan MR
Curr Osteoporos Rep; 2017 Jun; 15(3):162-170. PubMed ID: 28432594
[TBL] [Abstract][Full Text] [Related]
13. Co-expression network analysis of long noncoding RNAs (IncRNAs) and cancer genes revealsSFTA1P and CASC2abnormalities in lung squamous cell carcinoma.
Huang GQ; Ke ZP; Hu HB; Gu B
Cancer Biol Ther; 2017 Feb; 18(2):115-122. PubMed ID: 28118064
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of NUPR1 inhibits the proliferation of glioblastoma cells via ERK1/2, p38 MAPK and caspase-3.
Li J; Ren S; Liu Y; Lian Z; Dong B; Yao Y; Xu Y
J Neurooncol; 2017 Mar; 132(1):15-26. PubMed ID: 28000106
[TBL] [Abstract][Full Text] [Related]
15. Using miRNA-Analyzer for the Analysis of miRNA Data.
Guzzi PH; Tradigo G; Veltri P
Microarrays (Basel); 2016 Dec; 5(4):. PubMed ID: 27983673
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse.
Krzeminski P; Corchete LA; García JL; López-Corral L; Fermiñán E; García EM; Martín AA; Hernández-Rivas JM; García-Sanz R; San Miguel JF; Gutiérrez NC
Oncotarget; 2016 Dec; 7(49):80664-80679. PubMed ID: 27811368
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates.
Gallo Cantafio ME; Nielsen BS; Mignogna C; Arbitrio M; Botta C; Frandsen NM; Rolfo C; Tagliaferri P; Tassone P; Di Martino MT
Mol Ther Nucleic Acids; 2016 Jun; 5(6):. PubMed ID: 27327137
[TBL] [Abstract][Full Text] [Related]
18. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in multiple myeloma and related bone disease.
Rossi M; Tagliaferri P; Tassone P
Ann Transl Med; 2015 Dec; 3(21):334. PubMed ID: 26734644
[TBL] [Abstract][Full Text] [Related]
20. Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients.
Calura E; Bisognin A; Manzoni M; Todoerti K; Taiana E; Sales G; Morgan GJ; Tonon G; Amodio N; Tassone P; Neri A; Agnelli L; Romualdi C; Bortoluzzi S
Oncotarget; 2016 Jan; 7(3):2367-78. PubMed ID: 26496024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
